logo
Select company
Select metric
$ -14.56MEarning Before Interest & Taxes (EBIT)
VS
Market
27
Sector
58
Industry
73
History
60
$ 1.06Close
$ 0.85 - $ 4.86 52-Week Range
Ticker Information

Ticker

MRKR

Company Name

MARKER THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MARKER THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MRKR - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -14.56M
3/31/2025$ -12.73M
12/31/2024$ -10.68M
9/30/2024$ -9.69M
6/30/2024$ -10.37M
3/31/2024$ -5.66M
12/31/2023$ -8.23M
9/30/2023$ -9.29M
6/30/2023$ -13.23M
3/31/2023$ -24.99M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MARKER THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -25.28M.
  • Over the past 5 years, MARKER THERAPEUTICS INC's average EBIT has been $ -23.63M.
  • The median EBIT for MARKER THERAPEUTICS INC during this period was $ -25.13M
  • MARKER THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ -5.66M.
  • The lowest EBIT recorded by MARKER THERAPEUTICS INC in the same timeframe $ -43.01M

MARKER THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
LPCN : LIPOCINE INC $ -4.51MBOLT : BOLT BIOTHERAPEUTICS INC $ -50.71MXAIR : BEYOND AIR INC $ -39.51MTRAW : TRAWS PHARMA INC $ 87.91MINM : INMED PHARMACEUTICALS INC $ -7.79MLGVN : LONGEVERON INC $ -18.54MLEXX : LEXARIA BIOSCIENCE CORP $ -11.39MNBY : NOVABAY PHARMACEUTICALS INC $ 3.32MNRXS : NEURAXIS INC $ -7.09MIBIO : IBIO INC $ -18.16M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

MRKR - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -43.01M

Minimum

Mar 31, 2022

$ -5.66M

Maximum

Mar 31, 2024

$ -23.63M

Average

$ -25.13M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.79M with a standard deviation of $ 130.84M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.79M
median$ 971K
std$ 130.84M